Items Tagged ‘Stages I-II Gastric Cancer’

January 4th, 2016

FDA Clears Marketing Approval for Device to Reduce Hair Loss during Chemotherapy

By

The United States Food and Drug Administration (FDA) cleared for marketing the first cooling cap to reduce hair loss due to chemotherapy. The cooling cap (Dignitana DigniCap Cooling System) is to be used for female breast cancer patients who are undergoing chemotherapy. Certain types of chemotherapy are strongly associated with causing hair loss, whereupon hair […]

View full entry

Tags: alopecia, Breast Cancer, digitana Dignicap Cooling System, fda, Gastric Cancer, hair loss, News, Stages I-II Gastric Cancer, Stages III-IV Gastric Cancer


May 14th, 2015

Reolysin® Receives FDA Designation for Gastric Cancer

By

The U.S. Food and Drug Administration (FDA) has granted an Orphan Drug Designation (ODD) to Reolysin®, an injectable cancer-killing virus, for the treatment of gastric cancer. Oncolytics Biotech® Inc. recently announced the designation in a press release. The FDA grants ODDs in order to advance the evaluation and development of products that demonstrate promise for […]

View full entry

Tags: cancer killing virus, Gastric Cancer, injectable, News, Reolysin, reovirus, Stages I-II Gastric Cancer, Stages III-IV Gastric Cancer


February 20th, 2015

U.S. FDA Issues Warning about Certain Type of Endoscope

By

The U.S. Food and Drug Administration (FDA) has issued a Safety Communication about a certain type of endoscope­—specifically the device used in endoscopic retrograde cholangiopancreatography (ERCP). According to the FDA, the device may be difficult to clean effectively and may spread dangerous bacteria among patients. An endoscope is thin, tube-like instrument that’s used to look […]

View full entry

Tags: cancer screening, endoscope, fda, fda warning, Gastric Cancer, News, Recurrent Gastric Cancer, Screening/Prevention Gastric Cancer, Stages I-II Gastric Cancer, Stages III-IV Gastric Cancer


September 25th, 2012

Adjuvant Radiochemotherapy Demonstrates Benefit in Gastric Cancer

By

Adjuvant radiochemotherapy provides strong and persistent benefit in patients who have undergone curative gastric resection, according to the long-term results of a study published in the Journal of Clinical Oncology.[1] Gastric cancer refers to cancer of the stomach. Though gastric cancer has a relatively low incidence in the United States, it is the second leading cause […]

View full entry

Tags: Gastric Cancer, News, Stages I-II Gastric Cancer, Stages III-IV Gastric Cancer


June 24th, 2011

XELOX May Improve Survival in Gastric Cancer

By

The chemotherapy regimen referred to as XELOX may improve overall survival compared with observation alone in stages II and III gastric (stomach) cancer; however, data are still immature and longer follow-up is necessary. These results were presented in a late-breaking abstract at the 2011 annual meeting of the American Society of Clinical Oncology (ASCO). Gastric […]

View full entry

Tags: Gastric Cancer, News, Stages I-II Gastric Cancer, Stages III-IV Gastric Cancer